ELAVL1 and lung carcinoma: Similarly, folate receptor-α (FRA) is overexpressed in lung cancer cells, allowing folic acid to be conjugated to nanoparticles encapsulating HuR siRNA for targeted delivery of FRA and accurate release of HuR siRNA.